Biweekly vs Triweekly low dose intravenous ketamine acute series for severe major depression: A case report

Background: One third of the patients with Major Depression Disorder (MDD) fail to respond to conventional antidepressant treatments - treatment resistant depression (TRD). Low-dose IV ketamine (LDIVK) treatment has become a promising solution for these patients. However, infusion regimens for LDIVK...

Full description

Bibliographic Details
Main Authors: Hernandorena Carolina, Gutiérrez Gilmar, Cabrera Abreu Casimiro, Vazquez Gustavo
Format: Article
Language:English
Published: Elsevier 2023-12-01
Series:Journal of Affective Disorders Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666915323001580